Evidence map›Paper›PMID 20107587›Full record

ArticleJournal of toxicology2009

The severity of autism is associated with toxic metal body burden and red blood cell glutathione levels.

J B Adams, M Baral, E Geis, J Mitchell, J Ingram, A Hensley, I Zappia, S Newmark, E Gehn, R A Rubin and 3 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Journal of toxicology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04312152 (Randomized, Placebo-controlled, Cross-over, Double-blind Study of a Metabolic Support Therapy With Q10 Ubiquinol and a Multivitamin B and E Complex in Two Cohorts of Patients With Idiopathic and Syndromic Autism), which is not on this map. Cited by 59 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed, 4 pooled it
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04312152 naunknown statusnot on this mapstarted 2019, after this paper: background citation

Randomized, Placebo-controlled, Cross-over, Double-blind Study of a Metabolic Support Therapy With Q10 Ubiquinol and a Multivitamin B and E Complex in Two Cohorts of Patients With Idiopathic and Syndromic Autism (Phelan-McDermid Syndrome)

TypeinterventionalSponsorAntonio PersicoRan2019 to 2023Enrolled200ConditionsAutism Spectrum Disorder, Phelan-McDermid SyndromeArmsQ10 Ubiquinol, Vitamin E, Multi-Vitamin B complex
3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 4 syntheses or guidelines pooled it, 160 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Porphyrinuria in Autism Spectrum Disorder: A Review.Current medicinal chemistry · 2024
    Review
  15. Article
  16. Article
  17. De-implementation of Low-Value Practices for Autism Spectrum Disorder.Clinical child and family psychology review · 2023
    Review
  18. Plants (Basel, Switzerland) · 2023
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 1 country.

J B AdamsDivision of Basic Medical Sciences, Southwest College of Naturopathic Medicine, Tempe, AZ 85282, USA.
M Baral
E Geis
J Mitchell
J Ingram
A Hensley
I Zappia
S Newmark
E Gehn
R A Rubin
K Mitchell
J Bradstreet
J M El-Dahr
Autism Research Institute · USSouthwest College of Naturopathic Medicine & Health Sciences · USDDC-I (United States) · USIntegrative Medicine Institute · USTulane University · USWhittier College · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study investigated the relationship of children's autism symptoms with their toxic metal body burden and red blood cell (RBC) glutathione levels. In children ages 3-8 years, the severity of autism was assessed using four tools: ADOS, PDD-BI, ATEC, and SAS. Toxic metal body burden was assessed by measuring urinary excretion of toxic metals, both before and after oral dimercaptosuccinic acid (DMSA). Multiple positive correlations were found between the severity of autism and the urinary excretion of toxic metals. Variations in the severity of autism measurements could be explained, in part, by regression analyses of urinary excretion of toxic metals before and after DMSA and the level of RBC glutathione (adjusted R(2) of 0.22-0.45, P < .005 in all cases). This study demonstrates a significant positive association between the severity of autism and the relative body burden of toxic metals.

Identifiers

PMID20107587
PMCPMC2809421
OpenAlexW2170968899

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.